Partnership for Safe Medicines

Partnership for Safe Medicines has been a member of Linktree for 1 year and joined in July 2024. The social media accounts linked to from Partnership for Safe Medicines are: • Facebook • Instagram • TikTok • Spotify • YouTube • LinkedIn • X Besides social media accounts, safemedicines has populated their site with: • Five reasons adding peptides to the 503A bulk compounding lists may be more problematic than you realize – Partnership for Safe Medicines • Partnership for Safe Medicines urges FDA advisory committee to reject compounding of unapproved peptides – Partnership for Safe Medicines • Pharmacists beware: Diverted HIV medicines are being sold on online pharmacy-to-pharmacy platforms – Partnership for Safe Medicines • Partnership for Safe Medicines releases action plan to protect patients from unapproved compounded GLP-1s – Partnership for Safe Medicines • July 6, 2026: Judge blocks Colorado price cap on Enbrel – Partnership for Safe Medicines • June 29, 2026: PSM releases road map to improve patient safety amidst compounding boom – Partnership for Safe Medicines • June 22, 2026: Study links alternative funding programs to treatment delays – Partnership for Safe Medicines • June 15, 2026: Colorado becomes the second state given federal approval for Canadian drug importation program – Partnership for Safe Medicines • Partnership for Safe Medicines statement on FDA authorization of Colorado’s Section 804 Importation Program – Partnership for Safe Medicines • June 8, 2026: Reckless physicians prescribing experimental, black market weight loss drugs: “Why are we waiting?” – Partnership for Safe Medicines • Fishy Peptide Freight: What Q1 2026 import data reveals – Partnership for Safe Medicines • June 1, 2026: Up to 18 years for counterfeit pill conspirators in Massachusetts – Partnership for Safe Medicines • May 26, 2026: Maryland PDAB passes a price cap on Ozempic, as Virginia’s governor questions board efficacy – Partnership for Safe Medicines • Safety risks in the GLP-1 market: an update on weight loss medication, May 2026 – Partnership for Safe Medicines • May 11, 2026: Connecticut AG’s crackdown leads to major platform halting sales of “research grade” weight loss chemicals to U.S. – Partnership for Safe Medicines • May 18, 2026: FDA warns 503B compounding pharmacy for producing tirzepatide after shortage ended – Partnership for Safe Medicines • What’s master carton smuggling? – Partnership for Safe Medicines • Prescription Drug Freight Fraud Report, April 2026 – Partnership for Safe Medicines • January-July Pill Press Report • Visit our website to get the latest! • Using pharmacy-to-pharmacy marketplaces? Read this Suspicious Sales Surveillance Report – Partnership for Safe Medicines • May 4, 2026: FDA moves to restrict large-scale compounding of three weight loss drugs – Partnership for Safe Medicines • Read about Boyd brothers' sentences • April 27, 2026: Physician who illegally imported weight loss drugs gets probation – Partnership for Safe Medicines • April 20, 2026: Maryland becomes the second state to set a drug price cap – Partnership for Safe Medicines • March Drug Importation Madness – Partnership for Safe Medicines • Pill press update: July 2025 through January 2026 – Partnership for Safe Medicines • April 13, 2026: New video shows Mochi Health-affiliated pharmacy’s “corner cutting” – Partnership for Safe Medicines • April 6, 2026: Over 200 patients bought unapproved imported peptides from a now-indicted Utah physician – Partnership for Safe Medicines • March 30, 2026: A second pharmacy benefit manager settles suit with the FTC over insulin price inflation. – Partnership for Safe Medicines • Prescription drug freight fraud report, January 2026 – Partnership for Safe Medicines • March 24, 2026: Physician sentenced for administering expired injectables in long-running fraud scheme – Partnership for Safe Medicines • March 17, 2026: Safe Chain Solutions executives jailed for selling secondhand HIV meds – Partnership for Safe Medicines • March 10, 2026: Fake cancer drug distributor sentenced to almost four years in federal prison – Partnership for Safe Medicines • March 2, 2026: Europol’s 2025 Operation Shield yielded $38m in counterfeit and illegal medicines; domestic and international news sheds light on GLP-1 crimes – Partnership for Safe Medicines • February 23, 2026: State investigates whistleblower allegations of unsafe GLP-1 drug handling at Mochi Health-affiliated pharmacy. – Partnership for Safe Medicines • Update on drug importation, February 2026 – Partnership for Safe Medicines • PSM statement on ‘deeply concerning’ compounding of GLP-1 weight-loss pills – Partnership for Safe Medicines • February 17, 2026: Pennsylvania compounding pharmacy earns another FDA warning letter – Partnership for Safe Medicines • February 9, 2026: PBMs are the target of the spending bill and the FTC investigation – Partnership for Safe Medicines • February 2, 2026: Med spa owner charged with posing as a registered nurse – Partnership for Safe Medicines • January 26, 2025: Health Canada warns Canadians about the dangers of unapproved GLP-1s – Partnership for Safe Medicines • January 20, 2026: PSM research leads Google to enforce its pill press ad policy – Partnership for Safe Medicines • In July, Google promised to rid their platform of criminals selling pill presses. How’s it going? • Threats to HIV patients from criminals in the drug supply chain – Partnership for Safe Medicines • Why are price cap proposals on medicines dangerous to pharmacies and patients? – Partnership for Safe Medicines • January 12, 2026: New York Department of State warned consumers after citing 87 of 223 inspected med spas – Partnership for Safe Medicines • Prescription Drug Freight Fraud Report, October 2025 – Partnership for Safe Medicines • Med spas need stronger regulation – Partnership for Safe Medicines • FDA Alert: Supplements with undeclared drug ingredients – Partnership for Safe Medicines • January 5, 2026: CBP Cincinnati intercepted $407,000 in illegally imported medical products, including contact lenses, injections, and oncology drugs – Partnership for Safe Medicines • December 15, 2025: A Massachusetts man will plead to giving botulism-causing injections, says the U.S. Attorney’s Office – Partnership for Safe Medicines • December 7, 2025: FDA seized more fake Ozempic pens in the U.S. supply chain – Partnership for Safe Medicines • December 1, 2025: More botulism cases underscore the need for regulated, supervised Botox use – Partnership for Safe Medicines • Handout: The fake pill trade hasn’t gone away • November 24, 2025: Surveys examine online pharmacy use and patients’ perceived safety – Partnership for Safe Medicines • November 17, 2025: CNBC explores “alternative funding programs” forcing U.S. patients to take unregulated medicines – Partnership for Safe Medicines • November 10, 2025: FDA cracks down on sites supplying unapproved “Botox” – Partnership for Safe Medicines • November 3, 2025: Safe Chain’s Boyd brothers convicted for drug diversion and falsifying drug pedigrees – Partnership for Safe Medicines • Pill press update: January through June 2025 • October 27, 2025: U.K. regulators bust illicit site making unlicensed retatrutide and tirzepatide pens – Partnership for Safe Medicines • October 20, 2025: PSM leadership lends their expertise to scholarly journals – Partnership for Safe Medicines • October 15, 2025: A JAMA study promotes med spa regulation; a new documentary explores fake GLP-1s – Partnership for Safe Medicines • October 7, 2025: PSM shares prescription drug freight fraud findings with Democratic governors – Partnership for Safe Medicines • September 30, 2025: Florida agency requests $4 million more for $132 million empty warehouse – Partnership for Safe Medicines • September 22, 2025: Chinese executives sentenced for shipping 200 kilos of fentanyl precursors into the U.S. – Partnership for Safe Medicines • September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns FDA – Partnership for Safe Medicines • September 8, 2025: FDA launches an import alert listing safe GLP-1 manufacturers – Partnership for Safe Medicines • Prescription Drug Freight Fraud Report, September 2025 – Partnership for Safe Medicines • PSM co-signs a letter in support of an FDA mandate to destroy high-risk imports – Partnership for Safe Medicines • September 2, 2025: U.S. compounding restrictions have stemmed a flood of compounded semaglutide and tirzepatide – Partnership for Safe Medicines • Prescription Drug Freight Fraud Report, July 2025 • August 25, 2025: New press draws attention to the dangers of poorly regulated medspas • August 18, 2025: PSM, ADAP ask New York’s Board of Pharmacy to act in alleged fake medicine case • August 11, 2025: The FDA voices concern about sites that supply compounding ingredients • August 4, 2025: Pennsylvania pharmacy owner indicted and 14 licenses revoked in Ohio • July 28, 2025: Suspicious shipments of API continue to be sent to buyers in the U.S. • July 21, 2025: Inspection policy for all FDA-regulated products changed at ports of entry • Prescription Drug Freight Fraud Report, March 2025 • July 14, 2025: Counterfeit Keytruda peddlers sentenced in federal court • July 7, 2025: Google to block promotion of pill presses on ads and shopping platforms • June 30, 2025: Operation Pangea XVII nets $65 million in unapproved and counterfeit medicines • June 23, 2025: New botulism outbreaks tied to suspect Botox injections • June 16, 2025: Congress passes the HALT Fentanyl Act • June 9, 2025: Two Indian men pleaded guilty to smuggling counterfeit cancer medicine into the U.S. • June 2, 2025: FDA continues to protect Americans from unapproved and contaminated medicine • May 27, 2025: Global effort to disrupt darknet marketplaces yields 4,400 pounds of illicit drugs • May 19, 2025: Investigations raise questions about product safety at a Texas compounding company • May 12, 2025: FDA will expand unannounced foreign facility inspections, it says • May 4, 2025: New study suggests more adverse events associated with compounded GLP-1s than standard formulations • Counterfeit and compounded injected diabetes and obesity treatments — twin threats to American patients • April 28, 2025: SafeChain Solutions executive admits to criminal wire fraud in HIV drug diversion case • April 21, 2025: Kentucky doctor pleads guilty after injecting patients with semaglutide from unregistered sources • April 14, 2025: Regulators announce a third instance of counterfeit Ozempic injections in the U.S. drug supply • April 7, 2025: A study examines FDA-OCI’s enforcement actions over a five-year period • March 31, 2025: Senator asks how FDA will be accountable for unregulated active pharmaceutical ingredient (API) imports • March 24, 2025: Cost-saving AFPs are exposing Americans to risky, unregulated medicine • March 17, 2025: A Texas Pharmacist gets 17 years for $145m skin cream billing fraud • March 10, 2025: Patients transitioning from compounded diabetes / weight loss injections: Stick to licensed sources • March 3, 2025: Men who allegedly sold fake cancer drugs arraigned in Washington State • February 24, 2025: PSM report finds 80% of declared, unapproved semaglutide and tirzepatide slipped past customs over 17 months • February 10, 2025: NY woman allegedly injected mystery substances instead of Botox • February 3, 2025: A New York jury convicts precursor sellers • January 27, 2025: Another Canadian sentenced for fake prescription pill sales • January 21, 2025: PBMs pocketed billions by inflating medicine prices, says the FTC • February 5, 2025: Feds Nab Pill Press Seller in Vegas • Partnership for Safe Medicines Statement on Weight Loss Drug Ad Blitz • Prescription Drug Affordability Board Activity through January 27, 2025 • Ozempic maker claims Chicago medical spas deceptively sell unsafe copycats • Prescription Drug Affordability Board Activity through December 18, 2024 • Prescription Drug Affordability Boards, Upper Payment Limits, and the Drug Supply Chain • November 18, 2024: Regulators struggle with GLP-1s in the U.S. and abroad • November 11, 2024: Feds pursue companies selling fentanyl precursors • October 28, 2024: DOJ hands down indictments and patients harmed by formulary change • November 20, 2024: FTC: PBM's drive up drug prices • Prescription Drug Affordability Boards, Upper Payment Limits, and the Drug Supply Chain | Safe Medicines: True Crime and Medicine Safety • Texas Moms Unite to Combat the Fentanyl Epidemic After Losing Their Children • October 7, 2024: DEA warning – Dozens of fake online pharmacies sold millions of fake pills to customers in all 50 states • October 21, 2024: PSM advisory board member leads petition for tariffs over fentanyl precursors from China • September 30, 2024: 27 individuals indicted in Puerto Rico over wholesale distribution of misbranded and diverted medicine • September 9, 2024: A Mexican pharmacy sold a Texas man a known Ozempic counterfeit • September 23, 2024: Administrative complaint filed alleging insulin price inflation by pharmacy benefit managers • PSM Advocates for SHOP SAFE legislation at Anti-Counterfeiting Day on the Hill • August 19, 2024: Gilead Sciences files a second suit over the sale of black market HIV drugs • Compounding Patient Safety • Compounding Patient Harm • September 18, 2024: Black Market Med Scammers Back At It • Have patients been harmed by unsafe drug compounding? • July 22, 2024: A Michigan pharmacy sues supplier over fake Ozempic • July 15, 2024: What some fake Botox victims have endured • July 29, 2024: FDA issued new alert about compounded semaglutide • Report Date: 10/16/2023-12/1/2023 • August 5, 2024: Fight the Fakes’ paper looks at how to combat substandard and counterfeit medicine • Nearly half of online pharmacies selling weight loss drugs are operating illegally, study finds • July 8, 2024: U.S. legislators introduce a bill to curb fake pill sales on social media • Watch more of our videos on YouTube. • Listen to our podcast! • Read more about this on our website. • Watch our TikTok shorts. • More People Are Overdosing on Ozempic Alternatives